Vimarsana
Biggest News Aggregation in the World

Cns Disorders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cns Disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cns Disorders Today - Breaking & Trending Today

Central Nervous System Therapeutics Market to Reach $199.09 Billion, Globally By 2033 - Vimarsana News

Central Nervous System Therapeutics Market to Reach $199.09 Billion, Globally By 2033

Rise in prevalence of neurological conditions, rise in awareness and diagnosis of CNS disorders, surge in research and development by key players, and technological advancements in drug delivery are expected to provide lucrative opportunities for the growth of the market during the forecast period.Wilmington, New Castle, Delaware, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Central Nervous System (CNS) Therapeutics Market by Disease Type (Neurovascular D

Source: yahoo.com
Cerevance Announces Presentation at the 34th International Symposium on ALS/MND - Vimarsana News

Cerevance Announces Presentation at the 34th International Symposium on ALS/MND

BOSTON, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing novel precision therapeutics for central nervous system (CNS) diseases, today announced a poster presentation at the 34th International Symposium on ALS/MND, taking place in Basel, Switzerland from December 6 – 8, 2023. Presentation details Title: The two-pore potassium channel KCNK13 as a target to modulate neuroinflammation in Amyotrophic Lateral SclerosisOverview: Cerevance's unique NETSseq platform has the r

Source: yahoo.com
Glioblastoma Is the Most Aggressive Type of Brain Cancer, With No Cure - CNS Pharmaceuticals' Innovative Approach To Treatment Could Offer Hope - Vimarsana News

Glioblastoma Is the Most Aggressive Type of Brain Cancer, With No Cure - CNS Pharmaceuticals' Innovative Approach To Treatment Could Offer Hope

HOUSTON, TX / ACCESSWIRE / October 16, 2023 / Glioblastoma is the most aggressive type of brain cancer, with an average survival of only 14 to 16 months after diagnosis. There is currently no cure for glioblastoma, and it is a highly invasive tumor ...

Source: yahoo.com
The Global Medical Devices Market is expected to reach a - Vimarsana News

The Global Medical Devices Market is expected to reach a

The increased incidence of chronic disease and corresponding increases in disability-adjusted life years, technical developments in medical equipment, and...

Global Gene and Cell Therapies Targeting CNS Disorders Market 2021-2026 Featuring Emerging Drugs - NurOwn (BrainStorm Cell Therapeutics) & Neuro-Cells (Neuroplast) - Vimarsana News

Global Gene and Cell Therapies Targeting CNS Disorders Market 2021-2026 Featuring Emerging Drugs - NurOwn (BrainStorm Cell Therapeutics) & Neuro-Cells (Neuroplast)

Dublin, May 26, 2021 (GLOBE NEWSWIRE) -- The "Gene and Cell Therapies Targeting CNS Disorders - Market Insights and Market Forecast - 2026" report has been added to ResearchAndMarkets.com's offering. This 'Gene and Cell Therapies targeting CNS Disorders - Market Insights and Market Forecast - 2026' report delivers an in-depth understanding of the market trends of Gene and Cell Therapies targeting CNS Disorders in in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Gene and Cell Therapies targeting CNS Disorders market report pr...

Source: yahoo.com